Age-and center-stratified and adjusted for gender, diabetes duration, self-reported prevalence of heart disease, stroke, or cancer, physical activity, smoking status, educational attainment, body mass index, systolic blood pressure, HbA1c and storage time age, sex, employment status, smoking status, alcohol intake, duration of diabetes, body mass index, glycated hemoglobin, systolic blood pressure at enrolment, low-density lipoprotein cholesterol (LDL-C) related risk indicators (LDL-C _ 3.8 mmol/L and LDL-C < 2.8 mmol/L plus albuminuria), non-linear associations of high-density lipoprotein cholesterol and triglyceride with cancer, use of glibenclamide, gliclazide, metformin, statins, fibrates, reninangiotensin system (RAS) inhibitors and insulin during follow-up etc 
